The Closed-door Meeting on Market Expansion of Chinese Biomedicine Enterprises in the ASEAN took place at SIP’s Jinji Lake Roadshow Center on Dec 9, gathering attendees from the political, business and academic circles of China and Singapore to discuss the kind of substantial help Chinese biomedicine enterprises need in their market expansion in the ASEAN.
At the event, the “Report on Accelerating Market Exploration in the ASEAN and Helping Chinese Biomedicine Enterprises Expand Global Market” was released. It gives a holistic picture of the drug administration system in the ASEAN, covering all the procedures from those concerning drug research and development to those for drug registration.
“We hope the report can draw more enterprises’ attention to the huge market in the ASEAN, and help them solve difficulties and challenges in seeking overseas development,” said the representative from Shanghai-based ASK Health when expounding on the report to the attendees.
December 10, 2020